MUSTANG BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2099 USD | -3.27% |
|
-32.72% | -84.45% |
| 15/05 | Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02/05 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MUSTANG BIO, INC. | Bio Therapeutic Drugs | -3.27% | -32.72% | -84.45% | -95.82% | -99.59% | 26.13L |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MBIO Stock
- Charts Mustang Bio, Inc.
- Comparison Chart
